Doi Y, Hibino M, Hase R, Yamamoto M, Kasamatsu Y, Hirose M, Mutoh Y, Homma Y, Terada M, Ogawa T, Kashizaki F, Yokoyama T, Koba H, Kasahara H, Yokota K, Kato H, Yoshida J, Kita T, Kato Y, Kamio T, Kodama N, Uchida Y, Ikeda N, Shinoda M, Nakagawa A, Nakatsumi H, Horiguchi T, Iwata M, Matsuyama A, Banno S, Koseki T, Teramachi M, Miyata M, Tajima S, Maeki T, Nakayama E, Taniguchi S, Lim CK, Saijo M, Imai T, Yoshida H, Kabata D, Shintani A, Yuzawa Y, Kondo M.: A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19. A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19. Antimicrob Agents Chemother, 64(12): 64(12):e01897-2,2020.
Ogawa F, Kato H, Nakajima K, Nakagawa T, Matsumura R, Oi Y, Sakai K, Uchiyama M, Ohyama Y, Abe T, Takeuchi I: Therapeutic Strategy for Severe COVID-19 Pneumonia from Clinical Experience. European Journal of Inflammation, 18: 1-10,2020.
Ogawa F, Kato H, Sakai K, Nakamura K, Ogawa M, Uchiyama M, Nakajima K, Ohyama Y, Abe T, Takeuchi I: Environmental maintenance with effective and useful zoning to protect patients and medical staff from COVID-19 infection. Acute Med Surg, 7(1):e536,2020.
Kimura S, Fujita H, Handa H, Hiramoto N, Hosono N, Minamiguchi H, Takahashi T, Kato H, Ono T, Kanda Y, Kiyoi H, Matsumura I, Miyazaki Y: Japan Adult Leukemia Study Group (JALSG). Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group. Int J Hematol, 112(3):409-17,2020.
Kato H, Shimizu H, Shibue Y , Hosoda T, Iwabuchi K, Nagamine K, Saito H, Sawada R, Oishi T, Tsukiji J, Fujita H, Furuya R, Masuda M, Akasaka O, Ikeda Y, Sakamoto M, Sakai K, Uchiyama M, Watanabe H, Yamaguchi N, Higa R, Sasaki A, Tanaka K , Toyoda Y, Hamanaka S, Miyazawa N, Shimizu A, Fukase F, Iwai S, Komase Y, Kawasaki T, Nagata I, Nakayama Y, Takei T, Kimura K, Kunisaki R, Kudo M, Takeuchi I, Nakajima H: Clinical Course of 2019 Novel Coronavirus Disease (COVID-19) in Individuals Present During the Outbreak on the Diamond Princess Cruise Ship. J Infect Chemother, 26(8):865-869,2020.
Grein J, Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D’Arminio Monforte A, Ismail S, Kato H, Lapadula G, L’Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T: Compassionate Use of Remdesivir for Patients with Severe Covid-19. New Engl J Med, 382(24):2327-2336,2020.
Nakajima K, Kato H, Yamashiro T, Izumi T, Takeuchi I, Nakajima H, Utsunomiya D: COVID-19 pneumonia: infection control protocol inside computed tomography suites. Japanese Journal of Radiology, 38(5):391-3,2020.
Watanabe Y, Yamaguchi Y, Watanabe Y, Asami M, Takamura N, Watanabe T, Kato H, Aihara M: HIV-associated psoriasis with fasciitis and arthritis successfully treated using antiretroviral therapy. J Dermatol, 47(11):e386-e387,2020.
Nakajima K, Ogawa F, Sakai K, Uchiyama M, Oyama Y, Kato H, Takeuchi I. A Case of Coronavirus Disease 2019 Treated With Ciclesonide. Mayo Clin Proc, 95(6):1296-1297,2020.
